Cholesterol 24-hydroxylase defect is implicated in memory impairments associated with Alzheimer-like Tau pathology-Reference-Cited by-同舟云学术

Cholesterol 24-hydroxylase defect is implicated in memory impairments associated with Alzheimer-like Tau pathology

Published:2015-09-10 Issue:21 Volume:24 Page:5965-5976
ISSN:0964-6906
Container-title:Human Molecular Genetics
language:en
Short-container-title:Hum. Mol. Genet.

Author:

Burlot Marie-Anne,Braudeau Jérôme,Michaelsen-Preusse Kristin,Potier Brigitte,Ayciriex Sophie,Varin Jennifer,Gautier Benoit,Djelti Fathia,Audrain Mickael,Dauphinot Luce,Fernandez-Gomez Francisco-Jose,Caillierez Raphaëlle,Laprévote Olivier,Bièche Ivan,Auzeil Nicolas,Potier Marie-Claude,Dutar Patrick,Korte Martin,Buée Luc,Blum David,Cartier Nathalie

Publisher

Oxford University Press (OUP)

Subject

Genetics (clinical),Genetics,Molecular Biology,General Medicine

Link

http://academic.oup.com/hmg/article-pdf/24/21/5965/17261868/ddv268.pdf

Reference66 articles.

1. Alzheimer's Disease

2. Tau protein isoforms, phosphorylation and role in neurodegenerative disorders11These authors contributed equally to this work.

3. Biochemistry of Tau in Alzheimer’s disease and related neurological disorders

4. Memory and mental status correlates of modified Braak staging

5. Modeling the Relation Between Neurofibrillary Tangles and Intellectual Status

Cited by 95 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Challenges and Opportunities for Consideration of Efavirenz Drug Repurposing for Alzheimer’s Disease Therapeutics;ACS Pharmacology & Translational Science;2024-09-06

2. Dysregulated expression of cholesterol biosynthetic genes in Alzheimer's disease alters epigenomic signatures of hippocampal neurons;Neurobiology of Disease;2024-08

3. Differential roles of lysosomal cholesterol transporters in the development ofC. elegansNMJs;Life Science Alliance;2024-07-31

4. The cholesterol 24-hydroxylase enzyme, CYP46A1, reduces overexpressed alpha-synuclein proteins in human cellular models of Parkinson’s disease.;2024-07-03

5. Unbiased insights into the multiplicity of the CYP46A1 brain effects in 5XFAD mice treated with low dose-efavirenz;Journal of Lipid Research;2024-06